Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Valganciclovir 450mg tablets
0503022B0AAAAAA
|
Valganciclovir hydrochloride | Valganciclovir hydrochloride | Infections | 101 |
|
Valganciclovir 50mg/ml oral solution sugar free
0503022B0AAADAD
|
Valganciclovir hydrochloride | Valganciclovir hydrochloride | Infections | 5 |
|
Valganciclovir 570mg/5ml oral liquid
0503022B0AAAEAE
|
Valganciclovir hydrochloride | Valganciclovir hydrochloride | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.